News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
High response rates in poor-risk population – Hagop Kantarjian
Photo of Dr. Hagop Kantarjian from obroncology.com
Jul 22, 2023, 17:56

High response rates in poor-risk population – Hagop Kantarjian

Our study of aza + ven + pevonedistat NEDD8-activating enzyme inhibitor in secondary AML & MDS/CMML after HMA failure. High response rates in poor-risk population. Data from randomized ph3 study in AML are awaited.

For article: Click here

Source: Hagop Kantarjian/Twitter

cancer Hagop Kantarjian Leukemia OncoDaily Oncology pevonedistat Research
Special Coverage
Insight
Oct 9, 2024, 12:36
Myeloma Paper of the Day, October 9th, suggested by Robert Orlowski
Blog
Oct 9, 2024, 12:28
MD Anderson Cancer Center and UICC collaborate to improve women's cancer care
Dialogues
Oct 9, 2024, 12:18
ASCO24 Updates: Dr. Daniel McFarland on Patient Portals and Oncology Communication
Blog
Oct 9, 2024, 12:05
Janet Woodcock has joined the Board of Directors of Every Cure
Blog
Oct 9, 2024, 12:04
Dana-Farber/Boston Children's ranked among the best pediatric cancer programs in the nation for 18th year in a row
Blog
Oct 9, 2024, 11:52
Addressing cancer disparities and inequalities for people with HIV - NCI Division of Cancer Control and Population Sciences
Blog
Oct 9, 2024, 11:49
The call for applications is open for the NIH/PEPFAR Local Implementation Science Network - NCI Center for Global Health
Blog
Oct 9, 2024, 11:42
Francisco J. Esteva: Rising breast cancer rates and disparities among women under 50
Insight
Oct 9, 2024, 11:40
Datopotamab Deruxtecan Trial Shows Negative OS in TROPION-Lung 01 - Panot Sainamthip
Blog
Oct 9, 2024, 11:35
Amol Akhade: The Tyranny of Non-Inferiority Trials
Blog
Oct 9, 2024, 11:30
Scientific publication on bias assessment in epidemiological studies - IARC
Blog
Oct 9, 2024, 11:08
Stereotactic Ablative Radiation trial results published in Red Journal - ESTRO